<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To investigate the relationship between the expression of transgelin-2 and the clinicopathological factors of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> and evaluate the value of transgelin-2 in prognostic assessment of the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Using tissue microarray and immunohistochemical methods, we examined transgelin-2 of 120 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients received surgical treatment from September 2002 to April 2004, including 74 male and 46 female, age from 26 to 89 years </plain></SENT>
<SENT sid="2" pm="."><plain>Analyzed the relationship between transgelin-2 and both the clinicpathologcial features and prognosis of the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> by using χ² test and Kaplan-Meier survival analysis </plain></SENT>
<SENT sid="3" pm="."><plain>Cox proportion hazard regression analysis was used to study the independent prognostic factors </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The positive rate of transgelin-2 expression was 69.2% in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The transgelin-2 expression correlated with differentiation degree (χ² = 5.420), lymph nodes <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (χ² = 45.577), distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (χ² = 12.009), and TNM staging (χ² = 47.577) </plain></SENT>
<SENT sid="6" pm="."><plain>The survival time was (39 ± 5) months in patients with positive expression of the trangelin-2, while (59 ± 3) months in patients with negative expression </plain></SENT>
<SENT sid="7" pm="."><plain>The patient's survival time was statistically correlated with the transgelin-2 expression (P = 0.003) </plain></SENT>
<SENT sid="8" pm="."><plain>Distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (RR = 8.318, 95%CI: 4.119 - 16.790), lymph nodes <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (RR = 2.794, 95%CI: 1.246 - 6.263) and transgelin-2 expression (RR = 1.834, 95%CI: 1.118- 2.973) were independent prognostic factors in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The expression of transgelin-2 is correlated with clinicopathological features and prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, may be the potential marker of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and the prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>